A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Measuring Live-Cell mRNA Translational Dynamics with Split Luminescent Tagging in HEK293 Cells

67 views

DOI:

10.3791/70840

August 14th, 2026

* These authors contributed equally

In This Article

Summary

Here, we present a flexible, high-throughput-compatible method for measuring live mRNA translation dynamics in cellulo in HEK293s, using split luminescent tagging. This versatile assay distinguishes structural effects, supports in vitro transcription optimization, and streamlines mRNA therapeutic development.

Abstract

The swift vaccine development to combat COVID-19 illustrated the potential for messenger RNA (mRNA) therapeutics to transform drug development. Like mature mRNA, in vitro transcribed mRNA possesses the same elements including a 5’ cap, untranslated regions (UTRs), coding sequence and a poly(A) tail. Previous work studying the effects these components have on mRNA translation has primarily utilized highly engineered reporter proteins which exhibit efficient translation and protein stability. With the structural elements of each mRNA differentially affecting their translation, it is imperative to identify the optimal design relevant to the therapeutic protein of interest (POI). To enable POI translation characterization, a split luciferase complementation system was employed. A short peptide tag (HiBiT), which can be fused to either terminus of the POI, associates with its complementary heterodimer (LgBiT) to reconstitute enzymatic activity in the presence of a cell-permeable substrate. To date, split luminescent tagging has been primarily used for high-throughput protein turnover studies. We have previously demonstrated how split luminescent tagging can be employed to enable high-throughput quantification of mRNA translation temporally in cellulo in HEK293 cells constitutively expressing the complementary heterodimer. Here, we further demonstrate the versatility of the assay and detail how this assay can be employed for optimizing in vitro transcription to reduce costs. The assay system can uniquely distinguish alterations in structural components whilst highlighting the effects of coding sequence optimization using non-engineered genes. Additionally, we demonstrate that a 4-fold reduction in 5’ cap concentration for in vitro transcription results in equivalent translation in cellulo. These findings illustrate how split luminescent tagging can be easily integrated into the mRNA therapeutic workflow, enabling monitoring of real-time mRNA-driven protein expression dynamics in cellulo thereby offering a versatile method for the advancement of mRNA-based therapeutics.

Introduction

Messenger RNA (mRNA) therapeutics and research applications have rapidly expanded in recent years, driven by the success of mRNA vaccines1,2 and the growing recognition of RNA’s versatility as a programmable biomolecule. A central challenge in this field is the ability to quantitatively and dynamically assess mRNA translation efficiency in diverse contexts. The method described here – leveraging a split luminescent tagging system – provides a flexible, scalable platform for studying live mRNA translation in cellulo3. The overall goal of this method is to enabl....

Access restricted. Please log in or start a trial to view this content.

Protocol

A graphical depiction of the entire protocol is shown in Figure 1.

1. Template preparation for in vitro transcription (IVT)

NOTE: To prepare the DNA template for IVT, ensure the plasmid DNA contains an RNA polymerase promoter (generally T7 or SP6), 5’ and 3’ UTRs, and the open reading frame of the POI (Figure 1).

  1. Linearize plasmid DNA using a restriction enzyme with a single-cutting site located after the 3’ UTR and assemble the reaction according to the manufacturer’s instructions. After incu....

Access restricted. Please log in or start a trial to view this content.

Results

There are several ways in which the cost-effectiveness of this protocol can be optimized. For example, the IVT reaction was miniaturized to half the volume recommended by the manufacturer, and it was found that the resulting yield satisfied the amount required for in cellulo experiments. It should be noted that sequence length and complexity impact IVT yield, so successful protocol optimization should yield at least 50 µg of mRNA per IVT reaction. Like IVT reaction kits, capping reagents also often cost a great .......

Access restricted. Please log in or start a trial to view this content.

Discussion

The field of mRNA therapeutics has expanded rapidly in recent years, underscoring the importance of sequence design and optimization as a critical stage in the development pipeline. Significant efforts have focused on building computational tools to predict the most effective RNA structures and compositions, with sequence optimization receiving particular attention8,9. While these tools are powerful, experimental validation of these designs is still an essential .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have no conflicts of interest to declare.

Acknowledgements

The authors thank Laura Itzhaki for the HEK293 LgBiT cell line. This work was supported by the British Heart Foundation project grant and translational award (G114642 and G919651 to CHW) and a GenScript Life Science Research Grant (CAPB).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Acetic AcidSigma-AldrichA6283Component of TAE buffer
AgaroseSigma-AldrichA9539Gel electrophoresis
Agilent 2100 BioanalyzerAgilentG2939BBioanalyser used for mRNA quality control
CLARIOstar Plus LuminometerBMG Labtech430-501S-FPlate reader/luminometer used for measuring luminescence
CleanCap AGTrilink BiotechnologiesN-71135' cap used for IVT
DMEM, high glucose, pyruvateThermo Fisher Scientific41966029Media used for culture of HEK293-LgBiT cells
DNase INew England BiolabsM0303Degrades DNA template post-IVT reaction
Dulbecco's Phosphate Buffered Saline (PBS)Sigma-AldrichD8537For cell washing and addition to plate to prevent evaporation
EDTA, pH 8.0, RNase-freeThermo Fisher ScientificAM9260Component of TAE buffer
Ethidium BromideSigma-AldrichE1510Stain for gel electrophoresis
Fetal Bovine Serum (FBS)Sigma-AldrichF7524Supplement added to DMEM
HiScribe T7 High Yield RNA Synthesis KitNew England BiolabsE2040In vitro transcription (IVT) kit
Leibovitz's L-15 Medium, no phenol redThermo Fisher Scientific21083027Media used for HEK293-LgBiT culture during luminescence measurements
L-glutamineThermo Fisher Scientific25030-024Supplement added to DMEM
Lipofectamine RNAiMAXThermo Fisher Scientific13778150Lipid-based transfection reagent
Lithium Chloride Precipitation SolutionThermo Fisher ScientificAM9480Alternative approach for mRNA purification post-IVT
Monarch Spin PCR & DNA Cleanup KitNew England BiolabsT1130Purification kit after plasmid linearization
NanoDrop One Microvolume UV-Vis SpectrophotometerThermo Fisher ScientificND-ONE-WSpectrophotometer used for quantifying DNA and mRNA concentration
Nano-Glo Endurazine Live Cell SubstratePromegaN2570Substrate required for luminescence added to L-15 media 
NucleoSpin RNA Cleanup KitMacherey-Nagel12708612Purifies mRNA post-IVT reaction
Nunc MicroWell 96-Well, Nunclon Delta-Treated, Flat-Bottom MicroplateThermo Fisher Scientific136101Plate used for HEK293-LgBiT plating and subsequent measurements
Opti-MEM Reduced Serum MediumThermo Fisher Scientific31985062Media used for transfection reaction
Phusion High-Fidelity PCR KitNew England BiolabsE0553PCR kit
RiboRuler High Range RNA LadderThermo Fisher Scientific11883993RNA ladder for gel electrophoresis
RNaseZapThermo Fisher ScientificR2020RNase decontamination spray
TRIZMA BaseSigma-AldrichT6066Component of TAE buffer
Trypsin-EDTA SolutionSigma-AldrichT4174Cell dissociation reagent
UltraPure DNase/RNase free Distilled WaterThermo Fisher Scientific10977035Used for template preparation and for IVT

References

  1. Polack FP et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383(27):2603-2615.
  2. Baden LR et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403-416.
  3. Ascanelli C, Lawrence E, Batho CAP, Wilson CH. A flexible, high-throughput system for studying live mRNA translation with HiBiT technology. Nucleic Acids Res. 2025;53(11).
  4. Qin S et al. mRNA-based therapeutics: Powerful and versatile tools to combat diseases. Signal Transduct Target Ther. 2022;7(1):166.
  5. Kariko K, Buckstein M, Ni H, Weissman D. Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside mod....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

mRNA TranslationLive Cell ImagingIn Vitro TranscriptionProtein Expression DynamicsLuciferase ComplementationCoding Sequence Optimization5 Cap ModificationmRNA Therapeutics